ARTICLE | Company News
Artery Therapeutics, Roche deal
February 15, 2010 8:00 AM UTC
The companies will co-develop Artery's apolipoprotein A-1 (APOA1) peptide mimetics. The deal includes Artery's lead, AT5261, which is in preclinical testing to treat atherosclerosis and prevent card...